🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Uterine Fibroids With Menorrhagia

Phase II Study of CMS-D002 Capsule for Uterine Fibroids With Menorrhagia NCT07402369Phase 21 site📍 Beijing Shenzhen Kangzhe Biotechnology Co., Ltd. · Tests: CMS-D002 Capsules 10 mg, CMS-D002 Capsules 25 mg, CMS-D002 Capsules 50 mg, Placebo Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids NCT06671548Phase 31 site📍 Beijing Qilu Pharmaceutical Co., Ltd. · Tests: Relugolix, Relugolix placebo to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia NCT07378098Phase 31 site📍 Seoul JW Pharmaceutical · Tests: KLH-2109+ Leurprorelin acetate Placebo, KLH-2109 Placebo + Leurprorelin acetate A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis NCT05862272Phase 3120 sites📍 Mobile📍 Chandler📍 Mesa Sumitomo Pharma Switzerland GmbH · Tests: Relugolix Combination Tablet
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy